FDAFDA · Food and drugs·Recall number D-0052-2021
Catapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0007-01
Published November 4, 2020 · Recall initiated: October 5, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
An extraneous peak was observed for dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Distributor
- Distributed Nationwide in the USA and Puerto Rico
- Lot
- Lot # 861135, C34139, EXP Nov 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.